fulvestrant has been researched along with Hypertension in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hay, M; Johnson, AK; Xue, B; Zhao, Y | 1 |
| Badaue-Passos, D; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B | 1 |
| Danalache, B; Gangal, M; Gutkowska, J; Jankowski, M; Wang, D | 1 |
| Cheng, J; Li, PY; Lu, TT; Tan, XQ; Wen, J; Yang, Y; Zeng, XR | 1 |
| Ikeda, K; Xu, JW; Yamori, Y | 1 |
| Bonz, AW; Ertl, G; Fritzemeier, KH; Hegele-Hartung, C; Hu, K; Jazbutyte, V; Muck, J; Nahrendorf, M; Neyses, L; Nordbeck, P; Pelzer, T; Segerer, S | 1 |
| Nishio, I; Tsuda, K | 1 |
| Hay, M; Lubahn, DB; Pamidimukkala, J; Xue, B | 1 |
| Bao, L; Bian, Z; Cox, D; Gustafsson, JA; Hodgin, J; Karas, RH; Lu, P; Mendelsohn, ME; Shaul, PW; Smithies, O; Thoren, P; Zhu, Y | 1 |
9 other study(ies) available for fulvestrant and Hypertension
| Article | Year |
|---|---|
Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Data Interpretation, Statistical; Estradiol; Estrogens; Fulvestrant; Hypertension; Injections, Intraventricular; Irbesartan; Male; Mice; Microscopy, Confocal; Oxidative Stress; Reactive Oxygen Species; Spin Labels; Subfornical Organ; Telemetry; Tetrazoles | 2008 |
Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Brain; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertension; Infusion Pumps, Implantable; Male; Orchiectomy; Ovariectomy; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sex Factors; Sodium Chloride; Sympathetic Nervous System; Time Factors | 2009 |
Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fibrosis; Fulvestrant; Genistein; Hypertension; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; Ovariectomy; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; RNA, Messenger; Vasotocin; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
[β-estradiol activates BK(Ca) in mesenteric artery smooth muscle cells of post-menopause women].
Topics: Aged; Estradiol; Female; Fulvestrant; Humans; Hypertension; Large-Conductance Calcium-Activated Potassium Channels; Mesenteric Arteries; Middle Aged; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Postmenopause; Receptors, Estrogen | 2012 |
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents | 2004 |
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression; Hemodynamics; Hypertension; In Vitro Techniques; Magnetic Resonance Imaging; Models, Animal; Myocardium; Myosin Heavy Chains; Organ Size; Ovariectomy; Papillary Muscles; Random Allocation; Rats; Rats, Inbred SHR; Tamoxifen; Ventricular Myosins | 2005 |
A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation.
Topics: Aged; Analysis of Variance; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Hypertension; Membrane Fluidity; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Postmenopause; S-Nitroso-N-Acetylpenicillamine; Selective Estrogen Receptor Modulators; Tamoxifen | 2005 |
Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.
Topics: Angiotensin II; Animals; Blood Pressure; Consciousness; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Ganglionic Blockers; Heart Rate; Hypertension; Injections, Intraventricular; Lateral Ventricles; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovariectomy; Vasoconstrictor Agents | 2007 |
Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta; Blood Pressure; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Guanidines; Humans; Hypertension; In Vitro Techniques; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroarginine; Patch-Clamp Techniques; Phenylephrine; Potassium Channels; Receptors, Estrogen; Vasoconstriction | 2002 |